Cover Image

Ulcerative injection-site reaction associated with dupilumab therapy

Saved in:

Bibliographic Details
Main Authors:	Michael Phan, BS (Author), Anthony Linfante, MD (Author), Kathleen Kroger, MD (Author)
Format:	Book
Published:	Elsevier, 2020-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024)

Methotrexate injection site reactions: Case report and literature review
by: Japsimran Kaur, BS, et al.
Published: (2022)

Liraglutide-induced injection site reaction
by: Nada Fouda Neel, et al.
Published: (2019)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021)

Injection site reactions due to the use of biologics in patients with psoriasis: A retrospective study
by: Yun Kyung Jang, MD, et al.
Published: (2023)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

Delayed type hypersensitivity injection site reaction and tolerance induction to liraglutide for the treatment of obesity
by: Martina Yaneva, MD, et al.
Published: (2023)

Lichenoid-granulomatous drug reactions to dupilumab: A report of 2 cases
by: Zahra Rehan, BSc, et al.
Published: (2023)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021)

Clinical characteristics of monkeypox vaccine injection site reactions: A cohort of seven patients
by: Anthony A. Gaspari
Published: (2024)

Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
by: Kailyn Valido, BS, et al.
Published: (2024)

Dupilumab as an adjuvant treatment for keloid-associated symptoms
by: Audrey Jia Shin Wong, BS, et al.
Published: (2021)

Resolution of dupilumab-associated alopecia areata with dosage modification
by: Maansi Kulkarni, BS, et al.
Published: (2022)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
by: Nicole Edmonds, BA, et al.
Published: (2022)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

Epidermolysis bullosa pruriginosa responding to dupilumab
by: Rebecca C. Clawson, BS, et al.
Published: (2021)

Infectious pseudochromhidrosis in the setting of dupilumab use
by: Molly E. Kuo, BS, et al.
Published: (2022)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
by: Ryan Jay, BA, BS, et al.
Published: (2022)

Dupilumab for the treatment of pityriasis lichenoides chronica
by: Charissa N. Obeng-Nyarko, MS, et al.
Published: (2024)

Response to 'Eruptive keratoacanthomas associated with dupilumab therapy'
by: Alexandra Patchinsky, et al.
Published: (2023)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Effects of dupilumab on keloid stabilization and prevention
by: Ashley Wittmer, MSc, et al.
Published: (2023)

Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction
by: Satoshi Nakamizo, et al.
Published: (2014)

Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?
by: Ian F. Cook
Published: (2017)

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
by: Zi-Yi Choo, BS, et al.
Published: (2023)

A case of leukocytoclastic vasculitis in a patient on dupilumab
by: Michelle S. Bach, BS, et al.
Published: (2023)

Recalcitrant anal and genital pruritus treated with dupilumab
by: E.J. Yang, BS, et al.
Published: (2018)

Successful treatment of Brunsting-Perry pemphigoid with dupilumab
by: Franklin R. Blum, BS, et al.
Published: (2021)

Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation
by: Ashley Torkan Zilberstein, MD, et al.
Published: (2022)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
by: Makoto Ito, MD, et al.
Published: (2020)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023)

Lichen planus pemphigoides successfully treated with dupilumab
by: Peter Yi Ch'en, BS, et al.
Published: (2023)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
by: Birgit Sadoghi, et al.
Published: (2021)

Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study
by: Matteo M, et al.
Published: (2023)

Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination
by: Younes Benyamna, et al.
Published: (2022)